Valthos
New York, US · Founded 2024 · Delaware corporation · 3 known investors
Valthos develops AI systems to identify biological threats and design medical countermeasures in real time for biodefense applications.
Founders & leadership
KM
Kathleen McMahonExecutive Officer, Director
TV
Tess Van StekelenburgDirector
Investors · 3
Competitors · 6
by search overlapPulse25 shared keywords
Altos Labs4 shared keywordsAltos Labs develops computational and scientific approaches to reverse disease through breakthrough medicines, operating research institutes focused on cell health, computation, and drug discovery.
citybiz4 shared keywordsNot applicable - this is a media/news site
Czytaj więcej4 shared keywords
Kartosthera4 shared keywords
Avantos3 shared keywordsAvantos is an AI-native operating system for client management that uses AI agents to handle onboarding, servicing, and growth workflows while integrating with existing enterprise technology stacks. The platform targets financial services and enterprise software companies.
Companies competing with Valthos for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$27.3MraisedApr 2026 · 5 investors · Other TechnologyRule 506(b)
▶$27.3MraisedApr 2026 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Tess Van StekelenburgDirector
- Kathleen McMahonExecutive Officer, Director
- Offering amount
- $27.5M
- Amount sold
- $27.3M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Valthos Raises $30M in Seed Financingfinsmes.com · 2025
- Valthos Raises $30M from OpenAI, Lux Capital, Founders Fund to Build Next-Generation Biodefensefinance.yahoo.com · 2025
- Biodefense Startup Valthos Emerges From Stealth With $30M Funding From OpenAI, Thiel’s Founders Fund | citybizcitybiz.co · 2025
- OpenAI Backs a New Venture Trying to Thwart AI Bio-Attacks - Bloombergbloomberg.com · 2025
- OpenAI backs $30M investment in biosecurity startup Valthos to stop AI-engineered biological attacks - Tech Startupstechstartups.com · 2025